Pennant Group, Inc.
PNTG- Exchange
- Nasdaq
- Industry
- Services-Health Services
- SEC CIK
- 0001766400
No open-market purchases or sales by Pennant Group, Inc. insiders were filed in the last 90 days; 204 institutions reported holding it in 13F filings for Q2 2026, worth $1.17B in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 10, 2026
- $1.29B
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +15 vs. previous quarter
- 204
- 13F valueReported value at the end of Q2 2026
- $1.17B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $947.7M
- +36.3% year over year
- Net income, FY2025
- $29.6M
- +31.1% year over year
- Free cash flow, FY2025
- $36.3M
- +19.6% year over year
- Revenue, Q3 FY2026
- $302.3M
- +32.0% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 1.17M
- Shares sold short
- Change
- +23.2K
- +2.0% vs. previous
- Days to cover
- 4.06
- At average daily volume
Superinvestors holding PNTG, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding PNTG at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Pennant Group, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 (view filing)3:49 PM ET | Aug 6 | 4 days | Cheney Kirk SterlingEVP, GC and Corp Secy | SSale | −1.39K | $38.52 | −$53.7K | −7.0%18.4K after | |
| Aug 10, 2026 (view filing)3:49 PM ET | Aug 6 | 4 days | Guerisoli BrentChief Executive Officer | SSale | −4.29K | $38.52 | −$165.1K | −4.1%99.5K after | |
| Aug 10, 2026 (view filing)3:48 PM ET | Aug 6 | 4 days | Steik Jason PaulChief Clinical Officer | SSale | −1.39K | $38.52 | −$53.7K | −8.4%15.1K after | 10b5-1 |
| Jul 14, 2026 (view filing)12:16 PM ET | Jul 10 | 4 days | Guerisoli BrentChief Executive Officer | SSale | −3.16K | $41.57 | −$131.3K | −3.0%103.8K after | 10b5-1 |
| Jul 9, 2026 (view filing)11:32 AM ET | Jul 7 | 2 days | Guerisoli BrentChief Executive Officer | SSale | −3.17K | $40.51 | −$128.2K | −3.0%100.7K after | 10b5-1 |
| May 27, 2026 (view filing) | May 22 | 5 days | Guerisoli BrentChief Executive Officer | SSale | −4.51K | $35.08 | −$158.1K | −4.4%97.7K after | 4 lots10b5-1 |
| Aug 7, 2025 (view filing) | Jul 28 | 10 daysLate | Cheney Kirk SterlingEVP, GC and Corp Secy | SSale | −880 | $23.34 | −$20.5K | −6.3%13.1K after | |
| Jul 31, 2025 (view filing) | Jul 28 | 3 daysLate | Guerisoli BrentChief Executive Officer | SSale | −4.00K | $23.34 | −$93.2K | −4.6%82.0K after | |
| May 23, 2025 (view filing) | May 20 | 3 daysLate | Stringfield JoAnneDirector | SSale | −5.00K | $29.47 | −$147.3K | −14.2%30.3K after | |
| May 5, 2025 (view filing) | May 1 | 4 days | Stringfield JoAnneDirector | SSale | −665 | $25.62 | −$17.0K | −2.1%30.3K after |
Top 10 13F holders, Q2 2026
See all 204 holdersThe largest institutional positions in Pennant Group, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 2,959,141 | $109.3M | 0.00% | +243,076+8.9% | Added |
| Van Berkom & Associates Inc. | 2,369,269 | $87.5M | 2.82% | −300,165−11.2% | Reduced |
| Wasatch Advisors Inc | 1,870,178 | $69.1M | 0.45% | +451,491+31.8% | Added |
| Turtle Creek Asset Management Inc. | 1,714,462 | $63.3M | 2.47% | +131,639+8.3% | Added |
| Vanguard Capital Management LLC | 1,480,881 | $54.7M | 0.00% | +29,913+2.1% | Added |
| Paradigm Capital Management Inc | 1,402,800 | $51.8M | 1.41% | −6,000−0.4% | Reduced |
| FMR LLC | 1,182,138 | $43.7M | 0.00% | +79,514+7.2% | Added |
| Provident Investment Management, Inc. | 939,208 | $34.7M | 3.37% | −43,807−4.5% | Reduced |
| Goldman Sachs Group Inc | 891,426 | $32.9M | 0.00% | +260,035+41.2% | Added |
| Geode Capital Management, LLC | 886,783 | $32.8M | 0.00% | +44,645+5.3% | Added |
Holders of 5% or more of PNTG
See all 2 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Pennant Group, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Van Berkom & Associates Inc. | 13G/A | 9.00%3.11M shares | +9.00 ppfrom 0.00% | Feb 10, 20253 filings | Jan 20, 2026 | SEC |
| Wasatch Advisors Inc | 13G | 5.40%1.87M shares | – | Feb 11, 20215 filings | Jul 17, 2026 | SEC |